Neoadjuvant chemohormonal therapy combined with radical prostatectomy and extended PLND for very high risk locally advanced prostate cancer: A retrospective comparative study-Reference-Cited by-同舟云学术

Neoadjuvant chemohormonal therapy combined with radical prostatectomy and extended PLND for very high risk locally advanced prostate cancer: A retrospective comparative study

Published:2019-12 Issue:12 Volume:37 Page:991-998
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Pan Jiahua,Chi Chenfei,Qian Hongyang,Zhu Yinjie,Shao Xiaoguang,Sha Jianjun,Xu Fan,Wang Yanqing,Karnes Robert J.,Dong Baijun,Xue Wei

Funder

National Natural Science Foundation of China

Science and Technology Commission of Shanghai Municipality

Shanghai Shenkang Hospital Development Center

Shanghai Municipal Education Commission

Shanghai Municipal Commission of Health and Family Planning

Pudong Health Bureau of Shanghai

Shanghai Jiao Tong University School of Medicine

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference27 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

2. Trend analysis of cancer incidence and mortality in China;Wei;Sci China Life Sci,2017

3. Urologic cancer in China;Pang;Jpn J Clin Oncol,2016

4. A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma;Shelley;Cancer Treat Rev,2009

5. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer;Sweeney;N Engl J Med,2015

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives;Clinical Genitourinary Cancer;2024-10

2. Dose compliance of estramustine phosphate in neoadjuvant chemohormonal therapy combined with degarelix acetate predicts the biochemical recurrence in patients with very high‐risk prostate cancer who underwent robot‐assisted radical prostatectomy;International Journal of Urology;2024-09-10

3. Magnetic resonance imaging‐based radiomics nomogram for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high‐risk non‐metastatic prostate cancer;Cancer Medicine;2024-07

4. A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy;Journal of Urology;2024-05

5. A new perspective on prostate cancer treatment: the interplay between cellular senescence and treatment resistance;Frontiers in Immunology;2024-04-17